Russell Investments Group
AQST icon

Russell Investments Group’s Aquestive Therapeutics AQST Stock Holding History

Russell Investments Group’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$939K Buy
226,163
+16,733
+8% +$67.9K ﹤0.01% 2248
2025
Q4 		$1.35M Buy
209,430
+46,045
+28% +$287K ﹤0.01% 2063
2025
Q3 		$913K Buy
163,385
+35,681
+28% +$154K ﹤0.01% 2238
2025
Q2 		$423K Buy
127,704
+2,207
+2% +$6.33K ﹤0.01% 2399
2025
Q1 		$364K Buy
125,497
+16,984
+16% +$51.4K ﹤0.01% 2405
2024
Q4 		$386K Buy
108,513
+40,626
+60% +$187K ﹤0.01% 2365
2024
Q3 		$338K Buy
+67,887
New +$264K ﹤0.01% 2377
2019
Q4 		– Sell
-14,625
Closed -$46K – 3081
2019
Q3 		$46K Buy
+14,625
New +$54.8K ﹤0.01% 2933

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return